Metraipolis › archive › dc_19fcbfa40b74

Pathomics Signature for Prognosis and CA19-9 Interception in Pancreatic Ductal Adenocarcinoma: A Real-Life, Multi-Center Study — Europe PMC PMID:41556438

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41556438
DOI
10.1002/advs.202515952
License (as archived)
solo-consultazione
Archived
2026-10-08T06:08:48.204Z
SHA-256 of the archived text
1b1bbe711cdf5801f6e42e2481867fe9d7ea01365f954abf1074afa12589addf
Stable URL of this page
https://metraipolis.com/documento/dc_19fcbfa40b74

How to cite

Pathomics Signature for Prognosis and CA19-9 Interception in Pancreatic Ductal Adenocarcinoma: A Real-Life, Multi-Center Study — Europe PMC PMID:41556438 — Europe PMC (en), https://europepmc.org/article/MED/41556438 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_19fcbfa40b74 (Metraipolis archive dc_19fcbfa40b74, sha256 1b1bbe711cdf5801f6e42e2481867fe9d7ea01365f954abf1074afa12589addf)
BibTeX
@misc{dc19fcbfa40b74,
  title = {Pathomics Signature for Prognosis and CA19-9 Interception in Pancreatic Ductal Adenocarcinoma: A Real-Life, Multi-Center Study — Europe PMC PMID:41556438},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41556438},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_19fcbfa40b74; sha256 1b1bbe711cdf5801f6e42e2481867fe9d7ea01365f954abf1074afa12589addf},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41556438. Agents can read the archived copy with the MCP tool read_document.